Table 1

Demographic data of patients suffering from sepsis receiving either placebo or high-dose antithrombin therapy

Placebo

Antithrombin


Number of patients (n)

16

17

Age (years)

56 ± 17

51 ± 19

Height (cm)

175 ± 4

169 ± 9

Weight (kg)

80.7 ± 22.5

75.9 ± 22.4

4-day survival rate (n)

16

16

28-day survival rate (n)

11

12

Acute Pathophysiology and Chronic Health Evaluation II score

52 ± 9.5

53 ± 12.6

Low-molecular-weight heparin at inclusion (IU/day)

6042 ± 1982

6388 ± 2205


Data presented as the mean ± standard deviation or n.

Gonano et al. Critical Care 2006 10:R160   doi:10.1186/cc5098

Open Data